Left Ventricular Mass Index in End-Stage Renal Disease Patients during Hemodialysis and Continuous Ambulatory Peritoneal Dialysis.
Int J Clin Pract
; 2023: 8816478, 2023.
Article
en En
| MEDLINE
| ID: mdl-38115951
ABSTRACT
Background:
One of the primary reasons for high mortality in end-stage renal disease (ESRD) is cardiovascular disease in patients with renal replacement therapy (RRT). Left ventricular hypertrophy (LVH) significantly predicts mortality and cardiovascular events.Objectives:
We assess the left ventricular mass index change in two dialysismethods:
hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD). The factors associated with increased left ventricular mass index (LVMI). Materials andMethods:
We recruit more than 50 HD patients and 45 CAPD patients with LVH of similar age, gender, dialysis duration, and LVMI for one-year follow-up.Results:
The LVMI in the group of HD patients after one year increased from 180.28 ± 45.32 g/m2 to 212.58 ± 66.22 g/m2 (p = 0.001), while the LVMI in the group of patients with CAPD increased from 190.16 ± 66.01 g/m2 to 197.42 ± 78 g/m2 (p = 0.32). Multivariable logistic regression analysis, we demonstrated that dialysis by HD (ß = -1,167, 95% CI 0.104-0.938, p = 0.036) and anemia treatment lower the goals (ß = 1.9566, 95% CI 1.466-34.094, p = 0.015) were two factors associated with the progression of the LVMI.Conclusion:
The LVH of end-stage renal disease patients with HD treatment is worse than CAPD treatment after a follow-up in one year. Dialysis by periodic hemodialysis and anemia treatment that fails to achieve the goal are risk factors associated with increased progression of LVMI in patients with ESRD.
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Diálisis Peritoneal Ambulatoria Continua
/
Anemia
/
Fallo Renal Crónico
Límite:
Humans
Idioma:
En
Revista:
Int J Clin Pract
Asunto de la revista:
MEDICINA
Año:
2023
Tipo del documento:
Article
País de afiliación:
Vietnam